Literature DB >> 19742144

5-Fluorouracil-induced cardiotoxicity during chemotherapy for adenocarcinoma of the small bowel.

Mohamed H Abou El Fadl1, Rajesh K Bagai, Timothy P Spiro, Hamad A Daw.   

Abstract

Entities:  

Year:  2009        PMID： 19742144      PMCID： PMC2739643     

Source DB:  PubMed          Journal:  Gastrointest Cancer Res        ISSN： 1934-7820


× No keyword cloud information.
  16 in total

1.  Cardiotoxicity of de Gramont's regimen: incidence, clinical characteristics and long-term follow-up.

Authors:  Nezih Meydan; Isil Kundak; Tugba Yavuzsen; Ilhan Oztop; Sabri Barutca; Ugur Yilmaz; Mehmet Niyazi Alakavuklar
Journal:  Jpn J Clin Oncol       Date:  2005-04-26       Impact factor: 3.019

Review 2.  [Cardiotoxicity of 5-fluorouracil].

Authors:  Luis Teixeira; Sonia Barry; Philippe Debourdeau; Ariel Cohen; Christophe Tournigand
Journal:  Bull Cancer       Date:  2004-11       Impact factor: 1.276

Review 3.  Fluorouracil cardiotoxicity.

Authors:  A J Anand
Journal:  Ann Pharmacother       Date:  1994-03       Impact factor: 3.154

Review 4.  [Acute cardiac toxicity of 5-fluorouracil: pharmacokinetic correlation].

Authors:  E Gamelin; L Gamelin; F Larra; A Turcant; P Alain; P Maillart; Y M Allain; J F Minier; J Dubin
Journal:  Bull Cancer       Date:  1991       Impact factor: 1.276

5.  Symptomatic cardiotoxicity with high-dose 5-fluorouracil infusion: a prospective study.

Authors:  S S Akhtar; K P Salim; Z A Bano
Journal:  Oncology       Date:  1993 Nov-Dec       Impact factor: 2.935

6.  Cardiotoxicity of high-dose continuous infusion fluorouracil: a prospective clinical study.

Authors:  M de Forni; M C Malet-Martino; P Jaillais; R E Shubinski; J M Bachaud; L Lemaire; P Canal; C Chevreau; D Carrié; P Soulié
Journal:  J Clin Oncol       Date:  1992-11       Impact factor: 44.544

7.  Capecitabine can induce acute coronary syndrome similar to 5-fluorouracil.

Authors:  N Frickhofen; F J Beck; B Jung; H G Fuhr; H Andrasch; M Sigmund
Journal:  Ann Oncol       Date:  2002-05       Impact factor: 32.976

Review 8.  Cardiotoxicity and cardioprotection during chemotherapy.

Authors:  H Hochster; C Wasserheit; J Speyer
Journal:  Curr Opin Oncol       Date:  1995-07       Impact factor: 3.645

Review 9.  Cardiotoxicity of 5-fluorouracil.

Authors:  P Alter; M Herzum; M Soufi; J R Schaefer; B Maisch
Journal:  Cardiovasc Hematol Agents Med Chem       Date:  2006-01

Review 10.  Acute cardiotoxicity during capecitabine treatment: a case report.

Authors:  A Bertolini; M Flumanò; O Fusco; A Muffatti; A Scarinci; G Pontiggia; M Scopelliti
Journal:  Tumori       Date:  2001 May-Jun
View more
  4 in total

Review 1.  Cardio-oncology: the Nuclear Option.

Authors:  Jorge A Alvarez; Raymond R Russell
Journal:  Curr Cardiol Rep       Date:  2017-04       Impact factor: 2.931

2.  The role and clinical effectiveness of multimodality imaging in the management of cardiac complications of cancer and cancer therapy.

Authors:  Raymond R Russell; Jonathan Alexander; Diwakar Jain; Indu G Poornima; Ajay V Srivastava; Eugene Storozynsky; Ronald G Schwartz
Journal:  J Nucl Cardiol       Date:  2016-06-01       Impact factor: 5.952

Review 3.  Management of ischemic coronary disease in patients receiving chemotherapy: an uncharted clinical challenge.

Authors:  Bibhu D Mohanty; Sudipta Mohanty; Yasin Hussain; Chandrasekhar Padmaraju; Sameer Aggarwal; Rebekah Gospin; Anthony F Yu
Journal:  Future Cardiol       Date:  2017-06-01

4.  Non-covalent interactions involving halogenated derivatives of capecitabine and thymidylate synthase: a computational approach.

Authors:  Adhip Rahman; Mohammad Mazharol Hoque; Mohammad A K Khan; Mohammed G Sarwar; Mohammad A Halim
Journal:  Springerplus       Date:  2016-02-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.